IP Library Assignment 034167/0286
Patent Assignment
Reel/Frame 034167/0286

Assignment of Assignor's Interest

Recorded: 2014-11-13 Pages: 12
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100-8900 GLENLYON PARKWAY, V5J 5J8, BURNABY BC, CANADA
Covered Property (1)
Site Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Patent: 9,345,780 →
Application: 14/043,682 →
Publication: US 2014/0256785
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 13, 2014
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; BUTLER, DAVID; JAYARAMAN, MUTHUSAMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 034167/0276 →
Change of Name Jun 23, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 042802/0375 →
Merger and Change of Name Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →